Cargando…

Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the Art

Venous thromboembolism (VTE), a disease entity comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a frequent and potentially life-threatening event. To date different agents are available for the effective treatment of acute VTE and the prevention of recurrence. For several years,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thaler, Johannes, Pabinger, Ingrid, Ay, Cihan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671349/ https://www.ncbi.nlm.nih.gov/pubmed/26664901 http://dx.doi.org/10.3389/fcvm.2015.00030

Ejemplares similares

Low extracellular vesicle–associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis
por: Hell, Lena, et al.
Publicado: (2018)

Rare Presentation of Deep Vein Thrombosis and Submassive Pulmonary Emboli Due to Hypercoagulable State With Supratherapeutic Anticoagulation
por: Rivera-Morales, Mark D, et al.
Publicado: (2021)

Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J’xactly) study
por: Okumura, Yasuo, et al.
Publicado: (2018)

Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study
por: Evans, Alison, et al.
Publicado: (2020)

Pulmonary Tuberculosis With Saddle Pulmonary Embolism and Deep Vein Thrombosis: A Rare Case Report
por: Subahi, Eihab A, et al.
Publicado: (2021)

Therapeutic or prophylactic anticoagulation in acute isolated distal deep vein thrombosis: protocol for a prospective, multicentre, single-blind, randomised controlled trial (TOP-IDDVT)
por: Zhou, Min, et al.
Publicado: (2022)

How I treat cancer-associated thrombosis
por: Moik, Florian, et al.
Publicado: (2020)

High fibrinogen and mixed proximal and distal thrombosis are associated with the risk of residual venous thrombosis in patients with posttraumatic deep vein thrombosis
por: Liu, Yating, et al.
Publicado: (2023)

Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function
por: Scheiner, Bernhard, et al.
Publicado: (2018)

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials
por: Moik, Florian, et al.
Publicado: (2020)

Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review
por: Moik, Florian, et al.
Publicado: (2021)

Plasma Clot Properties in Patients with Pancreatic Cancer
por: Thaler, Johannes, et al.
Publicado: (2023)

Anatomic distribution of lower extremity deep venous thrombosis is associated with an increased risk of pulmonary embolism: A 10-year retrospective analysis
por: Zhang, Jianjun, et al.
Publicado: (2023)

Extensive Deep Vein Thrombosis after Electrophysiology Study
por: Kwon, Chang Hee
Publicado: (2020)

The association between iliac vein compression degree and characteristics of first diagnosed left lower extremity deep vein thrombosis
por: Shi, Yadong, et al.
Publicado: (2022)

Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis
por: Grover, Steven P., et al.
Publicado: (2022)

Risk of Thromboembolism With Eltrombopag: A Case Report of Deep Vein Thrombosis and Bilateral Pulmonary Embolism
por: Ghumman, Ghulam Mujtaba, et al.
Publicado: (2023)

An Atypical Case of Morbid Obesity, Presenting With Deep Vein Thrombosis and Pulmonary Embolism
por: Chitkara, Akshit, et al.
Publicado: (2020)

Hyperglycemia may increase deep vein thrombosis in trauma patients with lower limb fracture
por: Liu, Xiaojie, et al.
Publicado: (2022)

Guidance for the treatment of deep vein thrombosis and pulmonary embolism
por: Streiff, Michael B., et al.
Publicado: (2016)

Upper Extremity Deep Vein Thrombosis and Asymptomatic Vein Occlusion in Patients With Transvenous Leads: A Systematic Review and Meta-Analysis
por: Duijzer, Daniël, et al.
Publicado: (2021)

Platelet accumulation in an endothelium-coated elastic vein valve model of deep vein thrombosis is mediated by GPIbα—VWF interaction
por: Baksamawi, Hosam Alden, et al.
Publicado: (2023)

Risk factors and a predictive model for nonfilter-associated inferior vena cava thrombosis in patients with lower extremity deep vein thrombosis
por: Gong, Maofeng, et al.
Publicado: (2023)

Iron Deficiency Anemia as a Rare Risk Factor for Recurrent Pulmonary Embolism and Deep Vein Thrombosis
por: Ezeh, Ebubechukwu, et al.
Publicado: (2021)

A Case of Antiphospholipid Syndrome Refractory to Secondary Anticoagulating Prophylaxis after Deep Vein Thrombosis-Pulmonary Embolism
por: Gu, Kang Mo, et al.
Publicado: (2014)

Searching for a Common Thrombo-Inflammatory Basis in Patients With Deep Vein Thrombosis or Peripheral Artery Disease
por: Kremers, Bram M. M., et al.
Publicado: (2019)

Association Between the Use of Pre- and Post-thrombolysis Anticoagulation With All-Cause Mortality and Major Bleeding in Patients With Pulmonary Embolism
por: Tan, Jiang-Shan, et al.
Publicado: (2022)

Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism
por: Streiff, Michael B., et al.
Publicado: (2016)

Deep Vein Thrombosis and Pulmonary Embolism in the Setting of Mycoplasma Infection
por: Saleem, Sandal, et al.
Publicado: (2020)

Anastrozole: Deep vein thrombosis and pulmonary embolism: case report
Publicado: (2021)

Tozinameran: Deep vein thrombosis and pulmonary embolism: case report
Publicado: (2021)

Cost-effectiveness of rivaroxaban compared with enoxaparin plus warfarin for the treatment of hospitalised acute deep vein thrombosis in China
por: Yang, Li, et al.
Publicado: (2020)

The Need to Anticoagulate Patients With Splenic Vein Thrombosis
por: Benjamin, Clara, et al.
Publicado: (2022)

Isolated proximal greater saphenous vein thrombosis and the risk of propagation to deep vein thrombosis and pulmonary embolism
por: Kim, Samuel H, et al.
Publicado: (2018)

Incidence and risk factors of deep vein thrombosis in patients with spinal cord injury: a systematic review with meta-analysis
por: Shang, Zhizhong, et al.
Publicado: (2023)

May-Thurner Syndrome With Pulmonary Embolism as the First Presentation Rather Than Deep Vein Thrombosis
por: Fasanya, Adebayo A, et al.
Publicado: (2016)

Prognostic Significance of Incidental Deep Vein Thrombosis in Patients with Cancer Presenting with Incidental Pulmonary Embolism
por: Barca-Hernando, Maria, et al.
Publicado: (2020)

Bilateral Popliteal Vein Thrombosis, Acute Pulmonary Embolism and Mild COVID-19
por: Suwanwongse, Kulachanya, et al.
Publicado: (2020)

Deep vein thrombosis and pulmonary embolism – Prevention, management, and anaesthetic considerations
por: Narani, Krishan Kumar
Publicado: (2010)

Critical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolism
por: Ogbonna, Kelechi C, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_afvft3vnanca1jto5j5gaeb1ui